Success Metrics

Clinical Success Rate
100.0%

Based on 2 completed trials

Completion Rate
100%(2/2)
Active Trials
1(20%)
Results Posted
50%(1 trials)

Phase Distribution

Ph phase_2
4
80%
Ph not_applicable
1
20%

Phase Distribution

0

Early Stage

4

Mid Stage

0

Late Stage

Phase Distribution5 total trials
Phase 2Efficacy & side effects
4(80.0%)
N/ANon-phased studies
1(20.0%)

Highest Phase Reached

Phase 2

Trial Status & Enrollment

Completion Rate

100.0%

2 of 2 finished

Non-Completion Rate

0.0%

0 ended early

Currently Active

1

trials recruiting

Total Trials

5

all time

Status Distribution
Active(1)
Completed(2)
Other(2)

Detailed Status

Completed2
unknown2
Active, not recruiting1

Development Timeline

Analytics

Development Status

Total Trials
5
Active
1
Success Rate
100.0%
Most Advanced
Phase 2

Trials by Phase

Phase 24 (80.0%)
N/A1 (20.0%)

Trials by Status

completed240%
active_not_recruiting120%
unknown240%

Recent Activity

1 active trials
Showing 5 of 5
active_not_recruitingphase_2

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

NCT02066220
unknownnot_applicable

SBRT/RT in Oligometastatic Stage IV NSCLC

NCT05647590
completedphase_2

Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer

NCT01991873
completedphase_2

Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial

NCT02045446
unknownphase_2

Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer

NCT03142282

Clinical Trials (5)

Showing 5 of 5 trials
NCT02066220Phase 2

International Society of Paediatric Oncology (SIOP) PNET 5 Medulloblastoma

Active Not Recruiting
NCT05647590Not Applicable

SBRT/RT in Oligometastatic Stage IV NSCLC

Unknown
NCT01991873Phase 2

Maintenance Therapy With 5-FU/FA Plus Panitumumab vs. 5-FU/FA Alone After Prior Induction and Re-induction After Progress for 1st-line Treatment of Metastatic Colorectal Cancer

Completed
NCT02045446Phase 2

Maintenance Chemotherapy Versus Consolidative Stereotactic Body Radiation Therapy (SBRT) Plus Maintenance Chemotherapy for Stage IV Non-Small Cell Lung Cancer (NSCLC): A Randomized Phase II Trial

Completed
NCT03142282Phase 2

Consolidative Radiotherapy Plus Maintenance Chemotherapy for Metastatic Colorectal Cancer

Unknown

All 5 trials loaded

Drug Details

Intervention Type
DRUG
Total Trials
5